The ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferens
- 8 June 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 181 (3) , 315-318
- https://doi.org/10.1016/0014-2999(90)90097-p
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- An examination of the putative σ-receptor in the mouse isolated vas deferensBritish Journal of Pharmacology, 1989
- Evidence for a multi-site model of the rat brain σ receptorEuropean Journal of Pharmacology, 1989
- Activation of the A10 mesolimbic system by the σ-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychoticEuropean Journal of Pharmacology, 1988
- Correlation of inhibitory potencies of putative antagonists for σ receptors in brain and spleenEuropean Journal of Pharmacology, 1988
- Classification and nomenclature of phencyclidine and sigma receptor sitesTrends in Neurosciences, 1987
- Guinea-pig vas deferens preparation may contain both receptors and phencyclidine receptorsEuropean Journal of Pharmacology, 1987
- Both the σ receptor-specific ligand(+)3-PPP and the PCP receptor-specific ligand TCP act in the mouse vas deferens via augmentation of electrically evoked norepinephrine releaseEuropean Journal of Pharmacology, 1987
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986